Sign inJoin waitlistJoin the waitlist

Robert Mannel

Director, Stephenson Cancer Center · University of Oklahoma College of Medicine

Credentials: · · · ·

History

Stephenson Cancer Center · University of Oklahoma College of Medicine
Present
University of Oklahoma College of Medicine
Present

Gynecologic Oncology
University of California
1986–1989
Obstetrics and Gynecology
Baylor Scott & White Medical Center - Baylor College of Medicine
1982–1986
University of Texas Medical Branch at Galveston School of Medicine
1978–1982

Research

Incorporation of bevacizumab in the primary treatment of ovarian cancer
New England Journal of Medicine · 2011 · 1,905 citations
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group…
Journal of Clinical Oncology · 2003 · 1,662 citations
Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2
Journal of Clinical Oncology · 2009 · 932 citations

Joan Walker
51 papers · 3 as a fellow
Kathleen Moore
28 papers · 8 as a resident
Krishnansu Tewari
22 papers
Bradley Monk
21 papers
DM
Donald Mcmeekin
20 papers
Michael Gold
20 papers · 10 as a fellow
RB
Robert Burger
19 papers
PD
Paul DiSilvestro
18 papers · 1 as a fellow
CA
Carol Aghajanian
15 papers
Lisa Landrum
14 papers · 5 as a fellow
RC
Robert Coleman
14 papers
David Miller
13 papers

Grants

NRG Oncology Network Group Operations Center
National Cancer Institute · U10
PI · $144.2M · Nrg Oncology Foundation, Inc.
2014–2032
Stephenson Cancer Center - Cancer Center Support Grant
National Cancer Institute · P30
Contact PI · $25.1M · University of Oklahoma Hlth Sciences Ctr
2018–2028
Lead Academic Participating Site for the Development and Conduct of NCTN Trials
National Cancer Institute · U10
Contact PI · $6.7M · University of Oklahoma Hlth Sciences Ctr
2014–2019
Cancer Center Planning Grant (P20)
National Cancer Institute · P20
Contact PI · $466.1K · University of Oklahoma Hlth Sciences Ctr
2002–2008

Clinical trials

Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
Study chair · Completed · Phase 3
Gynecologic Oncology Group
1998
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Site PI · Unknown · Phase 3
Gynecologic Oncology Group
2012